They are not immature investigators and they know the data will be repeated by others. Anyone would not gamble on this. Why did they do this "misrepresentation"? Did they believed that the result from normals would not differ from ms patients or because they were under the gun of GSK who still believe interleukin-7 plays an important role in autoimmune disease, although may not be not pivotal.